Inventor · disambiguated record
Lita Suwandi
Also filed as: SUWANDI LITA · SUWANDI LITA S
5 granted patents·7 pending applications·2 citations·filing 2005–2020
64Inventor score
Files withAGOSTON GREGORY E4VIIV HEALTHCARE UK LTD3GLAXOSMITHKLINE IP NO 2 LTD2ENTREMED INC1GLAXOSMITHKLINE IP DEV LTD1
Top patents by PatentIndex Score
12 records- 0164US9163023B2Compounds and methods for treating HIVVIIV HEALTHCARE UK LTD·Filed 2013·Granted Oct 20, 2015·1 cites·17 claims
- 0263US10112899B2Isoindoline derivatives for use in the treatment of a viral infectionVIIV HEALTHCARE UK LTD·Filed 2015·Granted Oct 30, 2018·1 cites·13 claims
- 0354US8158612B2Methods of treating disease states using antiangiogenic agentsAGOSTON GREGORY E·Filed 2008·Granted Apr 17, 2012·0 cites·18 claims
- 0452US7498322B2Antiangiogenic agentsENTREMED INC·Filed 2005·Granted Mar 3, 2009·0 cites·4 claims
- 0550US2011318393A1Substituted Pyrazole CompoundsLADOUCEUR GAETAN·Filed 2009·Application pending·0 cites
- 0648US2022298160A1Compounds useful in hiv therapyGLAXOSMITHKLINE IP NO 2 LTD·Filed 2020·Application pending·0 cites
- 0742US2022117993A1Compounds Useful in HIV TherapyGLAXOSMITHKLINE IP NO 2 LTD·Filed 2019·Application pending·0 cites
- 0841US2009029992A1Substituted pyrazole compoundsAGOSTON GREGORY E·Filed 2008·Application pending·0 cites
- 0939US10239840B2Benzoazepine derivativesVIIV HEALTHCARE UK LTD·Filed 2016·Granted Mar 26, 2019·0 cites·11 claims
- 1038US2007004689A1Antiangiogenic agentsAGOSTON GREGORY E·Filed 2006·Application pending·0 cites
- 1138US2021078988A1Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Application pending·0 cites
- 1234US2006063930A1Compositions and methods comprising proteinase activated receptor antagonistsAGOSTON GREGORY E·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lita Suwandi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →